Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium
Year: 2019
Type: conference-abstract
Source: Blood
Authors: N. Nora Bennani, Matthew J. Maurer, Loretta J. Nastoupil, Michael D. Jain, Julio C. Chavez, Amanda F Cashen, Saurabh Dahiya, Lazaros J. Lekakis, Patrick M Reagan, Olalekan O. Oluwole, Joseph P. McGuirk, Abhinav Deol, Alison R. Sehgal, Andre Goy, Brian T. Hill, Khoan Vu, Charalambos Andreadis, Javier Munoz, Aaron P. Rapoport, Julie M Vose, David B Miklos, Frederick L. Locke, Sattva S Neelapu, Yi Lin
Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Washington University in St. Louis, University of Miami, Sylvester Comprehensive Cancer Center, University of Rochester Medicine, University of Rochester, Vanderbilt University Medical Center, University of Kansas Medical Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, UPMC Hillman Cancer Center, Hackensack University Medical Center, Cleveland Clinic, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Banner MD Anderson Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Nebraska Medical Center, Stanford Medicine, Stanford University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2990627596